GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Cyclically Adjusted PS Ratio

Realcan Pharmaceutical Group Co (SZSE:002589) Cyclically Adjusted PS Ratio : (As of May. 02, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Realcan Pharmaceutical Group Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Realcan Pharmaceutical Group Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Realcan Pharmaceutical Group Co Cyclically Adjusted PS Ratio Chart

Realcan Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.39 0.27 0.27 -

Realcan Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.23 0.24 - -

Competitive Comparison of Realcan Pharmaceutical Group Co's Cyclically Adjusted PS Ratio

For the Medical Distribution subindustry, Realcan Pharmaceutical Group Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Realcan Pharmaceutical Group Co's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Realcan Pharmaceutical Group Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Realcan Pharmaceutical Group Co's Cyclically Adjusted PS Ratio falls into.



Realcan Pharmaceutical Group Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Realcan Pharmaceutical Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Realcan Pharmaceutical Group Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.331/114.6694*114.6694
=1.331

Current CPI (Mar. 2024) = 114.6694.

Realcan Pharmaceutical Group Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.815 98.200 2.119
201409 2.100 98.900 2.435
201412 2.196 99.000 2.544
201503 2.022 99.900 2.321
201506 3.881 99.500 4.473
201509 1.939 100.500 2.212
201512 2.185 100.600 2.491
201603 2.541 102.200 2.851
201606 2.112 101.400 2.388
201609 2.637 102.400 2.953
201612 3.497 102.600 3.908
201703 3.307 103.200 3.675
201706 3.607 103.100 4.012
201709 4.150 104.100 4.571
201712 4.413 104.500 4.842
201803 4.731 105.300 5.152
201806 5.585 104.900 6.105
201809 6.008 106.600 6.463
201812 6.597 106.500 7.103
201903 5.985 107.700 6.372
201906 5.969 107.700 6.355
201909 5.974 109.800 6.239
201912 5.630 111.200 5.806
202003 3.683 112.300 3.761
202006 4.802 110.400 4.988
202009 4.833 111.700 4.961
202012 5.539 111.500 5.696
202103 3.530 112.662 3.593
202106 5.077 111.769 5.209
202109 3.256 112.215 3.327
202112 2.602 113.108 2.638
202203 2.682 114.335 2.690
202206 2.331 114.558 2.333
202209 2.225 115.339 2.212
202212 1.016 115.116 1.012
202303 1.372 115.116 1.367
202306 1.342 114.558 1.343
202309 1.352 115.339 1.344
202312 1.273 114.669 1.273
202403 1.331 114.669 1.331

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Realcan Pharmaceutical Group Co  (SZSE:002589) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Realcan Pharmaceutical Group Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Realcan Pharmaceutical Group Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Realcan Pharmaceutical Group Co (SZSE:002589) Business Description

Traded in Other Exchanges
N/A
Address
No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.

Realcan Pharmaceutical Group Co (SZSE:002589) Headlines

No Headlines